Dr Reddys Laboratories Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 22.70 | 0.60 | (8.80) | 3.63 |
| Op profit growth | 5.07 | (4.90) | (31) | 2.62 |
| EBIT growth | 34.90 | (12) | (45) | (2.20) |
| Net profit growth | 114 | (27) | (39) | (8.80) |
| Profitability ratios (%) | ||||
| OPM | 14.10 | 16.50 | 17.40 | 23 |
| EBIT margin | 11 | 10 | 11.40 | 18.90 |
| Net profit margin | 11.60 | 6.63 | 9.10 | 13.70 |
| RoCE | 10.80 | 8.12 | 9.71 | 19.40 |
| RoNW | 3.60 | 1.91 | 2.60 | 4.75 |
| RoA | 2.84 | 1.35 | 1.94 | 3.52 |
| Per share ratios () | ||||
| EPS | 122 | 55 | 75.80 | 124 |
| Dividend per share | 25 | 20 | 20 | 20 |
| Cash EPS | 51.90 | (7.90) | 16 | 69.90 |
| Book value per share | 939 | 758 | 740 | 737 |
| Valuation ratios | ||||
| P/E | 25.60 | 37.90 | 34.70 | 24.60 |
| P/CEPS | 60 | (265) | 164 | 43.40 |
| P/B | 3.32 | 2.75 | 3.56 | 4.12 |
| EV/EBIDTA | 17.40 | 15.70 | 18.20 | 14.10 |
| Payout (%) | ||||
| Dividend payout | -- | 35 | 25.70 | 19.30 |
| Tax payout | 7.67 | (32) | (19) | (26) |
| Liquidity ratios | ||||
| Debtor days | 94.60 | 100 | 102 | 96.40 |
| Inventory days | 66.80 | 73.60 | 69.60 | 60.10 |
| Creditor days | (40) | (45) | (40) | (35) |
| Leverage ratios | ||||
| Interest coverage | (20) | (18) | (26) | (36) |
| Net debt / equity | 0.13 | 0.38 | 0.37 | 0.23 |
| Net debt / op. profit | 0.81 | 2.04 | 1.83 | 0.80 |
| Cost breakup () | ||||
| Material costs | (32) | (28) | (26) | (24) |
| Employee costs | (19) | (23) | (22) | (20) |
| Other costs | (35) | (33) | (35) | (33) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Revenue | 17,517 | 14,281 | 14,196 | 15,568 |
| yoy growth (%) | 22.70 | 0.60 | (8.80) | 3.63 |
| Raw materials | (5,554) | (4,040) | (3,697) | (3,759) |
| As % of sales | 31.70 | 28.30 | 26 | 24.10 |
| Employee costs | (3,380) | (3,215) | (3,107) | (3,117) |
| As % of sales | 19.30 | 22.50 | 21.90 | 20 |
| Other costs | (6,112) | (4,675) | (4,921) | (5,107) |
| As % of sales | 34.90 | 32.70 | 34.70 | 32.80 |
| Operating profit | 2,470 | 2,351 | 2,472 | 3,585 |
| OPM | 14.10 | 16.50 | 17.40 | 23 |
| Depreciation | (1,163) | (1,077) | (1,027) | (939) |
| Interest expense | (98) | (79) | (63) | (83) |
| Other income | 621 | 155 | 172 | 295 |
| Profit before tax | 1,830 | 1,350 | 1,554 | 2,859 |
| Taxes | 140 | (438) | (297) | (751) |
| Tax rate | 7.67 | (32) | (19) | (26) |
| Minorities and other | -- | 34.40 | 34.90 | 22.90 |
| Adj. profit | 1,970 | 947 | 1,292 | 2,131 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 2,026 | 947 | 1,292 | 2,131 |
| yoy growth (%) | 114 | (27) | (39) | (8.80) |
| NPM | 11.60 | 6.63 | 9.10 | 13.70 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Profit before tax | 1,830 | 1,350 | 1,554 | 2,859 |
| Depreciation | (1,163) | (1,077) | (1,027) | (939) |
| Tax paid | 140 | (438) | (297) | (751) |
| Working capital | 2,656 | 542 | (877) | (1,644) |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 3,463 | 377 | (647) | (475) |
| Capital expenditure | 8,133 | 8,594 | 5,843 | 3,102 |
| Free cash flow | 11,596 | 8,971 | 5,196 | 2,627 |
| Equity raised | 17,436 | 16,776 | 17,501 | 18,545 |
| Investments | 2,677 | 2,090 | 1,913 | 2,766 |
| Debt financing/disposal | 4,524 | 8,238 | 8,424 | 7,620 |
| Dividends paid | -- | 332 | 331 | 411 |
| Other items | -- | -- | -- | -- |
| Net in cash | 36,233 | 36,407 | 33,366 | 31,969 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | (18) | 29.50 | 83 | 82.90 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 15,616 | 13,994 | 12,489 | 12,179 |
| Net worth | 15,599 | 14,024 | 12,572 | 12,262 |
| Minority interest | ||||
| Debt | 2,210 | 3,838 | 5,071 | 4,919 |
| Deferred tax liabilities (net) | 2 | 47.30 | 195 | 162 |
| Total liabilities | 17,811 | 17,909 | 17,838 | 17,343 |
| Fixed assets | 8,385 | 10,125 | 10,439 | 10,255 |
| Intangible assets | ||||
| Investments | 2,678 | 2,587 | 2,298 | 2,110 |
| Deferred tax asset (net) | 1,220 | 432 | 541 | 678 |
| Net working capital | 5,323 | 4,543 | 4,297 | 3,913 |
| Inventories | 3,507 | 3,358 | 2,909 | 2,853 |
| Inventory Days | 73.10 | -- | 74.30 | 73.30 |
| Sundry debtors | 5,028 | 3,987 | 4,053 | 3,799 |
| Debtor days | 105 | -- | 104 | 97.70 |
| Other current assets | 2,202 | 1,755 | 2,042 | 1,735 |
| Sundry creditors | (1,666) | (1,455) | (1,607) | (1,342) |
| Creditor days | 34.70 | -- | 41.10 | 34.50 |
| Other current liabilities | (3,748) | (3,101) | (3,100) | (3,132) |
| Cash | 205 | 223 | 264 | 387 |
| Total assets | 17,811 | 17,909 | 17,838 | 17,343 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Sep-2020 | Jun-2020 | Mar-2020 | Dec-2019 | Sep-2019 |
|---|---|---|---|---|---|
| Gross Sales | 4,897 | 4,418 | 4,432 | 4,384 | 4,801 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 4,897 | 4,418 | 4,432 | 4,384 | 4,801 |
| Other Operating Income | 14.20 | 9 | 17.10 | 13.30 | 12 |
| Other Income | 58.50 | 94.80 | 84.10 | 84.90 | 65.70 |
| Total Income | 4,969 | 4,521 | 4,533 | 4,482 | 4,879 |
| Total Expenditure ** | 3,755 | 3,305 | 3,500 | 4,686 | 3,749 |
| PBIDT | 1,215 | 1,216 | 1,033 | (204) | 1,130 |
| Interest | 25.20 | 23.30 | 23 | 15.20 | 30.30 |
| PBDT | 1,189 | 1,193 | 1,010 | (219) | 1,099 |
| Depreciation | 317 | 292 | 274 | 287 | 313 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 172 | 317 | 41.70 | 174 | 211 |
| Deferred Tax | (71) | (11) | (87) | (141) | (532) |
| Reported Profit After Tax | 772 | 595 | 781 | (538) | 1,107 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 772 | 595 | 781 | (538) | 1,107 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 772 | 595 | 781 | (538) | 1,107 |
| EPS (Unit Curr.) | 46.50 | 35.90 | 47.10 | (32) | 66.80 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 83.10 | 83.10 | 83.10 | 83.10 | 83.10 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 24.80 | 27.50 | 23.30 | (4.60) | 23.50 |
| PBDTM(%) | 24.30 | 27 | 22.80 | (5) | 22.90 |
| PATM(%) | 15.80 | 13.50 | 17.60 | (12) | 23.10 |
